Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
55,315,964
-
Share change
-
+811,532
-
Total reported value
-
$315,802,169
-
Put/Call ratio
-
128%
-
Price per share
-
$5.71
-
Number of holders
-
169
-
Value change
-
+$5,657,348
-
Number of buys
-
80
-
Number of sells
-
72
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2024
As of 30 Jun 2024,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,315,964 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., NEA Management Company, LLC, STATE STREET CORP, TANG CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Nuveen Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and Rock Springs Capital Management LP.
This page lists
168
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.